Author Index

Search or browse for an author across our entire electronic archive

Search results for: P
Results 281 - 290 of 1465 shown below

  • Park, S W

    S P Hong, J Y Park, T J Jeon, S Bang, S W Park, J B Chung, M-S Park, J Seong, W J Lee and S Y Song

    Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer

    advance online publication, 2008-02-26 00:00:00.000;

    doi:10.1038/sj.bjc.6604247

  • Park, S-J

    S-J Park, S Armstrong, C-H Kim, M Yu, K Robertson, M R Kelley and S-H Lee

    Lack of EGF receptor contributes to drug sensitivity of human germline cells

    advance online publication, 2005-01-11 00:00:00.000;

    doi:10.1038/sj.bjc.6602315

  • Park, S-Y

    S-Y Park, L R Wilkens, A A Franke, L Le Marchand, K K Kakazu, M T Goodman, S P Murphy, B E Henderson and L N Kolonel

    Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the Multiethnic Cohort

    advance online publication, 2009-06-16 00:00:00.000;

    doi:10.1038/sj.bjc.6605137

  • Park, W

    D H Lim, D Y Kim, M K Kang, Y I Kim, W K Kang, C K Park, S Kim, J H Noh, J W Joh, S H Choi, T S Sohn, J S Heo, C H Park, J O Park, J E Lee, Y J Park, H R Nam, W Park, Y C Ahn and S J Huh

    Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

    advance online publication, 2004-05-25 00:00:00.000;

    doi:10.1038/sj.bjc.6601896

  • Y H Park, M J Park, S H Ji, S Y Yi, D H Lim, D H Nam, J-I Lee, W Park, D H Choi, S J Huh, J S Ahn, W K Kang, K Park and Y-H Im

    Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

    advance online publication, 2009-02-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604941

  • Park, W S

    J W Lee, N J Yoo, Y H Soung, H S Kim, W S Park, S Y Kim, J H Lee, J Y Park, Y G Cho, C J Kim, Y H Ko, S H Kim, S W Nam, J Y Lee and S H Lee

    BRAF mutations in non-Hodgkin's lymphoma

    doi:10.1038/sj.bjc.6601371

  • Park, W-Y

    K-M Lee, J Abel, Y Ko, V Harth, W-Y Park, J-S Seo, K-Y Yoo, J-Y Choi, A Shin, S-H Ahn, D-Y Noh, A Hirvonen and D Kang

    Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women

    doi:10.1038/sj.bjc.6600761

  • Park, Y

    Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki

    Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605218

  • Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki

    Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    doi:10.1038/sj.bjc.6605295

  • C L Meinhold, Y Park, R Z Stolzenberg-Solomon, A R Hollenbeck, A Schatzkin and A Berrington de Gonzalez

    Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study

    advance online publication, 2009-09-29 00:00:00.000;

    doi:10.1038/sj.bjc.6605337

  • Park, Y H

    J Lee, W S Kim, Y H Park, S H Park, K W Park, J H Kang, S S Lee, S I Lee, S-H Lee, K Kim, C W Jung, Y C Ahn, Y H Ko and K Park

    Nasal-type NK/T cell lymphoma: clinical features and treatment outcome

    advance online publication, 2005-03-29 00:00:00.000;

    doi:10.1038/sj.bjc.6602502

  • Y H Park, B-S Kim, B-Y Ryoo and S H Yang

    A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

    advance online publication, 2006-03-21 00:00:00.000;

    doi:10.1038/sj.bjc.6603046

  • Y H Park, M J Park, S H Ji, S Y Yi, D H Lim, D H Nam, J-I Lee, W Park, D H Choi, S J Huh, J S Ahn, W K Kang, K Park and Y-H Im

    Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

    advance online publication, 2009-02-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604941

  • Park, Y J

    D H Lim, D Y Kim, M K Kang, Y I Kim, W K Kang, C K Park, S Kim, J H Noh, J W Joh, S H Choi, T S Sohn, J S Heo, C H Park, J O Park, J E Lee, Y J Park, H R Nam, W Park, Y C Ahn and S J Huh

    Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

    advance online publication, 2004-05-25 00:00:00.000;

    doi:10.1038/sj.bjc.6601896

  • K-A Yoon, J-L Ku, H S Choi, S C Heo, S-Y Jeong, Y J Park, N K Kim, J C Kim, P M Jung and J-G Park

    Germline mutations of the STK11 gene in Korean Peutz-Jeghers syndrome patients

    doi:10.1054/bjoc.1999.1125

  • Park, Y S

    S-H Lee, W K Kang, J Park, H Y Kim, J H Kim, S I Lee, J O Park, K Kim, C W Jung, Y S Park, Y-H Im, M H Lee and K Park

    Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

    advance online publication, 2004-06-08 00:00:00.000;

    doi:10.1038/sj.bjc.6601891

  • S T Kim, W K Kang, J H Kang, K W Park, J Lee, S-H Lee, J O Park, K Kim, W S Kim, C W Jung, Y S Park, Y-H Im and K Park

    Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602575